Table 7 Correlation of the levels of expression of cytoplasmic thymidine phosphorylase (TP-cyt) with clinical features

From: Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors

 

TP-cyt

 
 

No or low expression (%)

High expression (%)

P

Primary tumour site

   

 Oral cavity

6 (55)

5 (45)

 

 Oropharynx

9 (90)

1 (10)

0.009

 Hypopharinx

4 (100)

0 (0)

 

 Larynx

1 (17)

5 (83)

 

Type of disease

   

 Recurrence

5 (36)

9 (64)

0.007

 Primary

15 (88)

2 (12)

 
  1. TP-cyt: cytoplasmic thymidine phosphorylase.